Curtis A. Hanson

Curtis A. Hanson is a distinguished Clinical Professor at the Mayo Clinic College of Medicine and Science, affiliated with the Mayo Clinic Comprehensive Cancer Center and Department of Laboratory Medicine and Pathology. He specializes in diagnostic bone marrow hematopathology, clinical flow cytometry, and laboratory management, with a focus on hematologic malignancies and myelodysplastic syndromes.

• 1987 Residency - Anatomic and Clinical Pathology, University of Minnesota
• 1986 Fellowship - Hematopathology, University of Minnesota
• 1982 MD - Carver College of Medicine, University of Iowa
• 1978 BS - Nebraska Wesleyan University

His research spans hematopathology, genomic profiling in blood cancers, and prognostic modeling for myeloproliferative neoplasms. Collaborative studies with institutions in Italy and the Mayo Clinic have advanced understanding of clonal evolution in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.

Key publications highlight expertise in molecularly-informed risk stratification for essential thrombocythemia, polycythemia vera, and primary myelofibrosis. His work with the E1912 trial team established long-term outcomes for ibrutinib-rituximab in CLL compared to chemoimmunotherapy.

Scientific accolades include:

• 1999 Excellence in Leadership - Mayo Clinic
• 1997 Teacher of the Year - Department of Laboratory Medicine and Pathology
• 1988 Board Certification - American Board of Pathology (Hematology)
• 1987 Board Certification - Anatomic & Clinical Pathology

Professional leadership roles include chairing the American Clinical Laboratory Association and Mayo Clinic's Executive Committee for Laboratory Medicine. His advisory and grant activities focus on laboratory optimization, epigenetic research in hematologic disorders, and clinical practice standardization.